Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sinovac rises on Beijing flu vaccine contract
Yahoo/AP
Friday, October 14, 2011 - 11:38am
tags:
Beijing, Sinovac, vaccines
J&J Unit Cleared of Liability for Alleged Levaquin Injuries
Bloomberg
Friday, October 14, 2011 - 11:37am
tags:
JNJ, antibiotics, Levaquin, Ortho-McNeil-Janssen
Teva-Cephalon combination official, will have $20B in revenues
Bizjournals.com
Friday, October 14, 2011 - 11:27am
tags:
Teva Pharmaceuticals, M&A, Cephalon
Epizyme grabs $4M from partner GlaxoSmithKline
Bizjournals.com
Friday, October 14, 2011 - 11:24am
tags:
GSK, Epizyme, small molecule drugs
Bristol-Myers Skin-Cancer Drug Yervoy Rejected by U.K. Health Cost Agency
Bloomberg
Friday, October 14, 2011 - 11:23am
tags:
UK, Yervoy, Bristol-Myers Squibb, NICE, skin cancer
Option-based deals: How biotechs and big pharmas share R&D risks
Med City
Friday, October 14, 2011 - 11:18am
tags:
options, R&D, biotech, Big Pharma, Targacept, AstraZeneca
Ranbaxy recalls three drugs from UK market
Financial Express, India
Friday, October 14, 2011 - 11:17am
tags:
Ranbaxy, UK, recalls, Aciclovir, Oldaram, Tramadol, Fluconazole
Senators Want To Ease FDA Panel Conflict Rules
Pharmalot
Friday, October 14, 2011 - 11:15am
tags:
FDA, advisory panels, Senate
Depomed Falls After Menopause Drug Fails in One Objective
Bloomberg
Friday, October 14, 2011 - 11:14am
tags:
Depomed, menopause, Serada
Allos Therapeutics Says It Settled Lawsuits Contesting Acquisition by AMAG
Bloomberg
Friday, October 14, 2011 - 11:06am
tags:
Amag Pharmaceuticals, Allos, M&A
Forest Labs looks longterm for next product deals
Yahoo/Reuters
Friday, October 14, 2011 - 11:05am
tags:
Forest Labs, Lexapro, patents, Namenda
Why A Merck Dividend Increase Could Be Forthcoming
Seeking Alpha
Friday, October 14, 2011 - 11:03am
tags:
Merck, dividends
Diagenic Says Early Results for Early Alzheimer Tests Positive
Bloomberg
Friday, October 14, 2011 - 11:03am
tags:
Pfizer, Diagenic, Alzheimer's disease
Antibiotics developer Cempra braves tough market with $86M IPO
Fierce Biotech
Thursday, October 13, 2011 - 1:32pm
tags:
antibiotics, Cempra, IPO
Several Upcoming Catalysts In Play For Halozyme Therapeutics
Seeking Alpha
Thursday, October 13, 2011 - 1:31pm
tags:
Halozyme, diabetes, PH20
Trimeris, Synageva set date to vote on merger
Bizjournals.com
Thursday, October 13, 2011 - 1:24pm
tags:
Trimeris, Synageva, M&A
5 promising pancreatic cancer drugs
Fierce Biotech
Thursday, October 13, 2011 - 1:23pm
tags:
Amgen, Takeda, Ganitumab, KAEL-GemVax, GV1001, HyperAcute Pancreas, NewLink Genetics, GI-4000, GlobeImmune, MM-398, Merrimack Pharmaceuticals, pancreatic cancer
Will Impax Laboratories Disappoint Analysts Next Quarter?
Motley Fool
Thursday, October 13, 2011 - 12:56pm
tags:
Impax
Hep C Drug Updates: Vertex and Anadys
TheStreet.com
Thursday, October 13, 2011 - 12:21pm
tags:
Vertex, Anadys, hepatitis C, Incivek, setrobuvir
Weak cancer meds, Tamiflu take bite out of Roche sales
Fierce Pharma
Thursday, October 13, 2011 - 11:36am
tags:
Tamiflu, Roche, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.